Elevated lactate dehydrogenase in adjuvant BRAF and MEK inhibitor therapy does not have diagnostic significance in detecting melanoma recurrence
Information on the common increase in LDH in patients undergoing adjuvant therapy with dabrafenib with trametinib will avoid additional imaging studies in many situations and may prevent unnecessary emotional stress for patients.
Authors
- Łukasz Galus (ORCID: https://orcid.org/0000-0002-9515-1834)
- Jacek Mackiewicz (ORCID: https://orcid.org/0000-0002-2556-5900)
- Daria Tusień-Małecka
Institutions
- Poznan University of Medical Sciences (PL)
Publication Details
- Journal
- Współczesna Onkologia
- Published
- 2025-01-01
- DOI
- https://doi.org/10.5114/wo.2025.149038
- Primary Topic
- Melanoma and MAPK Pathways
- Type
- article
- Field-Weighted Citation Impact
- 0.00